SparingVision

0 followers


SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal d... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Stéphane Boissel

Collapse
Mehdi Gasmi
Chief Operating Officer
Hélène Grimm
General Counsel/directrice Juridique
Marie Uguen
SVP, Regulatory Affairs & QA
Florence Paliargues
VP Portfolio Program Management
Ryan Klimczak
VP, Intellectual Property
Anne-Sophie Gautron
Director Translational Sciences